Paolo Tombesi
Wednesday, July 24, 2019
Epizyme (NASDAQ: EPZM) $1.19b Paolo Tombesi named CFO x- Insmed CFO succeeds Matthew Ros x- Novartis Pharma CFO Admin Officer
Tombesi comp package: Base $455,000; Bonus Opportunity 40% of Base; Relocation: $100,000; Granted Stock Options 132,225 shares; award of 28,217 restricted stock units; 16,000 performance-based restricted stock units